/uccs/dachmarke-png.png)
/uccs/uccs-fellows/img_20210903_184437_contentbild_hochformat.jpg)
Jorge E. Duque Escobar has a background in pharmacy. His research career started with his PhD study at the Department of Clinical Pharmacology and Toxicology, where he worked with molecular biology methods and animal models to elucidate the role of a beta-cell-damaging kinase in the development of diabetes mellitus type 2. After his PhD, his work was awarded the Niemann Innovation Prize for Pharmacy 2018 and a research fellowship for a postdoctoral position (FFM) at UKE. He then joined the Cardiovascular Systems Medicine and Molecular Translation group (Prof. Tanja Zeller) at the University Center for Cardiovascular Science. He was fascinating by the idea of combining epidemiological and clinical data with molecular biology approaches to improve the understanding of the molecular mechanisms behind hypertension and cardiovascular diseases. Since human heart diseases are highly heterogenous at the molecular level an involve multiple organs, his vision is to promote a better understanding of the multifactorial events contributing to cardiovascular diseases by applying state-of-the-art methods within the immune system-kidney-heart axis.
/uccs/uccs_web_contentbild.png)